Clinical characteristics of asymptomatic carriers of novel coronavirus disease 2019: A multi-center study in Jiangsu Province

References

• National Health Commission of the People’s Republic of China. [accessed 2020 March 16].http://www.nhc.gov.cn/xcs/yqtb/202003/114113d25c1d47aabe68381e836f06a8.shtml
   Google Scholar
• World Health Organization Coronavirus disease. 2019. (COVID-19) situation report – 120; 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200419-covid-19-sitrep-120.pdf?sfvrsn=515cabfb_2
   Google Scholar
• Health Commission of Jiangsu Province. [accessed: 2020 March 15].http://wjw.jiangsu.gov.cn/art/2020/3/15/art_55449_9011939.html
   Google Scholar
• Lu R, Zhao X, Li J, et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–574.
   PubMed Web of Science ®Google Scholar
• Wan SX, Yi QJ, Fan SB, et al. Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP). medRxiv. 2020;2020:0210.20021832.
   Google Scholar
• He X, Lau EHY, Wu P, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020;26(5):672–675.
   PubMed Web of Science ®Google Scholar
• Kam KQ, Yung CF, Cui L, et al. A well infant with coronavirus disease 2019 with high viral load. Clin Infect Dis. 2020;71(15):847–849.
   PubMed Web of Science ®Google Scholar
• Mizumoto K, Kagaya K, Zarebski A, et al. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill. 2020;25(10):2000180.
   PubMedGoogle Scholar
• Bai Y, Yao L, Wei T, et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020;323(14):1406–1407.
   PubMed Web of Science ®Google Scholar
• Wei WE, Li Z, Chiew CJ, et al. Presymptomatic transmission of SARS-CoV-2 — singapore. Morb Mortal Wkly Rep. 2020;69(14):411–415.
   PubMed Web of Science ®Google Scholar
• Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020;382(10):970–971.
   PubMed Web of Science ®Google Scholar
• Zijian Feng, Qun Li, Yanping Zhang, et al. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020.China CDC Weekly. 2020;2(8):113–122. doi: https://doi.org/10.46234/ccdcw2020.032
   Google Scholar
• National Health Commission (NHC) of the PRC, National Administration of Traditional Medicine of the PRC. Guidance for corona virus disease 2019: prevention, control, diagnosis and management. Beijing: People’s Medical Publishing House; 2020.
   Google Scholar
• Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Han T, Chen J, et al. Clinical and autoimmune characteristics of severe and critical cases of COVID-19. Clin Transl Sci. 2020. [Epub ahead of print]. DOI:https://doi.org/10.1111/cts.12805.
   Google Scholar
• Chan JF, Lau SK, To KK, et al. Middle East Respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev. 2015;28(2):465–522.
   PubMed Web of Science ®Google Scholar
• Cecere TE, Todd SM, Leroith T. Regulatory T cells in arterivirus and coronavirus infections: do they protect against disease or enhance it? Viruses. 2012;4(5):833–846.
   PubMed Web of Science ®Google Scholar
• Li G, Fan Y, Lai Y, et al. Coronavirus infections and immune responses. J Med Virol. 2020;92(4):424–432.
   PubMed Web of Science ®Google Scholar
• Conti P, Ronconi G, Caraffa A, et al. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020;34(2):327–331.
   PubMed Web of Science ®Google Scholar
• Li J, Fan JG. Characteristics and mechanism of liver injury in 2019 coronavirus disease. J Clin Transl Hepatol. 2020;8(1):13–17.
   PubMed Web of Science ®Google Scholar
• Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–422.
   PubMed Web of Science ®Google Scholar
• Henter JI, Chow CB, Leung CW, et al. Cytotoxic therapy for severe avian influenza A (H5N1) infection. Lancet. 2006;367(9513):870–873.
   PubMed Web of Science ®Google Scholar
• Huff HV, Singh A. Asymptomatic transmission during the COVID-19 pandemic and implications for public health strategies. Clin Infect Dis. 2020 May;28:ciaa654. [Epub ahead of print].
   Google Scholar
• Kroon FP, Weiland HT, van Loon AM, et al. Abortive and subclinical poliomyelitis in a family during the 1992 epidemic in The Netherlands. Clin Infect Dis. 1995;20(2):454–456.
   PubMed Web of Science ®Google Scholar
• Mbabazi WB, Nanyunja M, Makumbi I, et al. Achieving measles control: lessons from the 2002-06 measles control strategy for Uganda. Health Policy Plan. 2009;24(4):261–269.
   PubMed Web of Science ®Google Scholar
• Smallman-Raynor MR, Cliff AD. Poliomyelitis: A World Geography. Emergence to Eradication. Oxford: Oxford University Press; 2006. p. 32.
   Google Scholar
• Miura F, Matsuyama R, Nishiura H. Estimating the asymptomatic ratio of norovirus infection during foodborne outbreaks with laboratory testing in Japan. J Epidemiol. 2018;28(9):382–387.
   PubMed Web of Science ®Google Scholar
• Mizumoto K, Kobayashi T, Chowell G. Transmission potential of modified measles during an outbreak, Japan, March‒May 2018. Euro Surveill. 2018;23(24):1800239.
   Google Scholar